Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. SCHERING-PLOUGH
  6. News
  7. All News
    SPL   US8066051017

SCHERING-PLOUGH

(SPL)
SummaryNewsCompany 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about SCHERING-PLOUGH
2009SCHERING-PLOUGH : Announces Sponsorship of Rabies-Control Projects in India
PR
2009SCHERING-PLOUGH : Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary En..
PR
2009SCHERING-PLOUGH : U.S. Food and Drug Administration Issues Complete Response Letter Regard..
PR
2009SCHERING-PLOUGH : Standard & Poor's Announces Changes to U.S. Indices
PR
2009SCHERING-PLOUGH : Reports Financial Results for 2009 Third Quarter
PR
2009SCHERING-PLOUGH : Nobilon Advances Intranasal Seasonal Influenza Vaccine Into Proof of Con..
PR
2009SCHERING-PLOUGH : Schedules Conference Call Webcast For 2009 Third Quarter Earnings
PR
2009SCHERING-PLOUGH : SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcu..
PR
2009SCHERING-PLOUGH : Declares Quarterly Dividends on Common Shares and Mandatory Convertible ..
PR
2009SCHERING-PLOUGH : Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Stu..
PR
2009SCHERING-PLOUGH : Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse..
PR
2009SCHERING-PLOUGH : New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their ..
PR
2009SCHERING-PLOUGH : Announces Two European Filings
PR
2009SCHERING-PLOUGH : ANNOUNCES FDA APPROVAL OF SAPHRIS(R) (asenapine): for acute treatment of..
PR
2009SCHERING-PLOUGH : Video: Schering-Plough Announces FDA Approval of SAPHRIS(R) (asenapine) ..
PR
2009SCHERING-PLOUGH : Announces Resolution of Litigations on U.S. Marketing of Generic Forms o..
PR
2009SCHERING-PLOUGH : Photos: New CLARITIN(R) Eye Relieves Itchy Eyes For Up To 12 Hours
PR
2009SCHERING-PLOUGH : PTC Therapeutics Announces Achievement of Major Milestone in Schering-Pl..
PR
2009SCHERING-PLOUGH : Shareholders Approve Merger With Merck
PR
2009SCHERING-PLOUGH : to Webcast Special Meeting of Shareholders
PR
2009SCHERING-PLOUGH : Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Actio..
PR
2009SCHERING-PLOUGH : /C O R R E C T I O N -- Schering-Plough Corporation/
PR
2009SCHERING-PLOUGH : Reports Proposed Settlement in Litigation Involving Planned Merger with ..
PR
2009SCHERING-PLOUGH : Schering profit rises
RE
2009SCHERING-PLOUGH : Reports Financial Results for 2009 Second Quarter
PR
2009SCHERING-PLOUGH : Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV
PR
2009SCHERING-PLOUGH : REMERON(R) Now Approved in Japan for the Treatment of Depression in Adul..
PR
2009SCHERING-PLOUGH : ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan..
PR
2009SCHERING-PLOUGH : Schedules Conference Call Webcast for 2009 Second Quarter Earnings
PR
2009SCHERING-PLOUGH : SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Mon..
PR
2009SCHERING-PLOUGH CP COM USD0.50 : Schering-Plough Declares Quarterly Dividends on Common Sh..
PR
2009SCHERING-PLOUGH CP COM USD0.50 : The New York Yankees' Mark Teixeira, National Foundation ..
PR
2009SCHERING-PLOUGH : Announces European Filing of SYCREST(R) (asenapine) for the Treatment of..
PR
2009SCHERING-PLOUGH : Critical Alerts for GS, SGP, GPS, PALM, and KWK Released by Seven Summit..
PR
2009SCHERING-PLOUGH : Valeant Grants Schering-Plough Exclusive Option in Japan for Taribavirin..
PR
2009SCHERING-PLOUGH : Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifung..
PR
2009SCHERING-PLOUGH : Announces Changes to its Global Collaboration with Novartis to Develop C..
PR
2009SCHERING-PLOUGH : Schedules Webcast For Annual Meeting of Shareholders
PR
2009SCHERING-PLOUGH : Flips the Switch on 1.7 MW Rooftop Solar Panel System, One of the Larges..
PR
2009SCHERING-PLOUGH : Highlights Hepatitis C Clinical Data Presentations at the European Assoc..
PR
2009SCHERING-PLOUGH : profit beats views; cost cuts help
RE
2009SCHERING-PLOUGH : Reports Financial Results for 2009 First Quarter
PR
2009SCHERING-PLOUGH : Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumato..
PR
2009SCHERING-PLOUGH : Video: CLARITIN Partners with NASCAR Driver Carl Edwards to Educate Mot..
PR
2009SCHERING-PLOUGH : Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza ..
PR
2009SCHERING-PLOUGH : Schedules Conference Call Webcast for 2009 First Quarter Earnings
PR
2009SCHERING-PLOUGH : FDA Approves an Expanded Indication for Peginterferon-Based Combination ..
PR
2009SCHERING-PLOUGH : Withdraws From Barclays Capital Global Healthcare Conference
PR
2009SCHERING-PLOUGH : to Webcast Presentation at Barclays Capital Global Healthcare Conference
PR
2009SCHERING-PLOUGH : European Commission and United States Food and Drug Administration (FDA)..
PR
2009SCHERING-PLOUGH : Video: Schering-Plough Introduces AFRIN(R) PureSea(TM): A Natural, Gentl..
PR
2009SCHERING-PLOUGH : Declares Quarterly Dividends on Common Shares and Mandatory Convertible ..
PR
2009SCHERING-PLOUGH : Announces Collaboration With World Health Organization to Provide Access..
PR
2009SCHERING-PLOUGH : Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatme..
PR
2009SCHERING-PLOUGH : Claritin(R) Renews Sponsorship With Allergy Sufferer and NASCAR Star Car..
PR
2009SCHERING-PLOUGH : Brooke Shields and the Makers of COPPERTONE(R) Join Together to Launch C..
PR
2009SCHERING-PLOUGH : Selects Benefit Advocates for Health Advocacy
PR
2009SCHERING-PLOUGH : New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available
PR
2009SCHERING-PLOUGH : U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in ..
PR
2009SCHERING-PLOUGH : to Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
PR
2009SCHERING-PLOUGH : Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Y..
PR
2008SCHERING-PLOUGH : Announces European Submission of Fertility Medicine Corifollitropin Alfa
PR
2008SCHERING-PLOUGH : Provides Update on Dividend Payment Date for Mandatory Convertible Prefe..
PR
2008SCHERING-PLOUGH : Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Thera..
PR
2008SCHERING-PLOUGH : Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convert..
PR
2008SCHERING-PLOUGH : CHMP Recommends Approval in the European Union (EU) for New Options for ..
PR
2008SCHERING-PLOUGH : Highlights R&D Pipeline Progress, Innovation and Breadth of Research Pro..
PR
2008SCHERING-PLOUGH : Provides Update on Boceprevir Clinical Development and Introduces Potent..
PR
2008SCHERING-PLOUGH : Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Tria..
PR
2008SCHERING-PLOUGH : Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating..
PR
2008SCHERING-PLOUGH : to Webcast R&D Update Meeting
PR
2008SCHERING-PLOUGH : to Appeal Jury Decision in Missouri Reimbursement Case
PR
2008SCHERING-PLOUGH : Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Vir..
PR
2008SCHERING-PLOUGH : Asenapine Meets Primary Endpoint in Long-Term Schizophrenia Relapse Prev..
PR
2008SCHERING-PLOUGH : Schering beats forecast, as Vytorin falls
RE
1  2Next
Upcoming sector events